Trial intelligence / Profile preview

Intensive versus conventional methotrexate management in early rheumatoid arthritis

NL-OMON21292Active, not recruiting

Sponsor

Initator: UMC Utrecht, Department of Rheumatology & Clin. Immunology, on behalf of the Utrecht Rheumatoid Arthritis Cohort study group (SRU), a regional collaboration of departments of rheumatology in the region of Utrecht, The Netherlands

Start

Jan 1999

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1